EXHIBIT 99.2
EMCORE CORPORATION
Pro Forma Condensed Consolidated Statement of Operations
(in thousands)
(unaudited)
| | | Year Ended September 30, 2005 | |
| | | As reported | | | Pro forma adjustments | | | Pro forma as adjusted | |
| | | | | | (a) | | | | |
Revenue | | $ | 127,603 | | $ | (12,236 | ) | $ | 115,367 | |
Cost of revenue | | | 106,746 | | | (10,721 | ) | | 96,025 | |
Gross profit | | | 20,857 | | | (1,515 | ) | | 19,342 | |
| | | | | | | | | | |
Operating expenses: | | | | | | | | | | |
Selling, general and administrative | | | 25,136 | | | (2,570 | ) | | 22,566 | |
Research and development | | | 17,429 | | | (2,738 | ) | | 14,691 | |
Total operating expenses | | | 42,565 | | | (5,308 | ) | | 37,257 | |
Operating loss | | | (21,708 | ) | | 3,793 | | | (17,915 | ) |
| | | | | | | | | | |
Other (income) expenses: | | | | | | | | | | |
Interest income | | | (1,081 | ) | | - | | | (1,081 | ) |
Interest expense | | | 4,844 | | | - | | | 4,844 | |
Equity in net loss of GELcore investment | | | 112 | | | - | | | 112 | |
Total other expenses | | | 3,875 | | | - | | | 3,875 | |
Loss from continuing operations | | $ | (25,583 | ) | $ | 3,793 | | $ | (21,790 | ) |
| | | | | | | | | | |
Per share data: | | | | | | | | | | |
Basic and diluted per share data: | | | | | | | | | | |
Loss from continuing operations | | $ | (0.54 | ) | $ | 0.08 | | $ | (0.46 | ) |
| | | | | | | | | | |
Weighted average number of shares outstanding used in basic and diluted per share calculations | | | 47,387 | | | 47,387 | | | 47,387 | |
The accompanying notes are an integral part of these pro forma condensed consolidated financial statements.
EMCORE CORPORATION
Pro Forma Condensed Consolidated Statement of Operations
(in thousands)
(unaudited)
| | | Nine Months Ended June 30, 2006 | |
| | | As reported | | | Pro forma adjustments | | | Pro forma as adjusted | |
| | | | | | (a) | | | | |
Revenue | | $ | 123,007 | | $ | (14,840 | ) | $ | 108,167 | |
Cost of revenue | | | 98,864 | | | (12,623 | ) | | 86,241 | |
Gross profit | | | 24,143 | | | (2,217 | ) | | 21,926 | |
| | | | | | | | | | |
Operating expenses: | | | | | | | | | | |
Selling, general and administrative | | | 26,445 | | | (2,549 | ) | | 23,896 | |
Research and development | | | 14,550 | | | (869 | ) | | 13,681 | |
Total operating expenses | | | 40,995 | | | (3,418 | ) | | 37,577 | |
Operating loss | | | (16,852 | ) | | 1,201 | | | (15,651 | ) |
| | | | | | | | | | |
Other (income) expenses: | | | | | | | | | | |
Interest income | | | (838 | ) | | - | | | (838 | ) |
Interest expense | | | 3,987 | | | - | | | 3,987 | |
Loss from convertible subordinated notes exchange offer | | | 1,078 | | | - | | | 1,078 | |
Equity in net loss of Velox investment | | | 332 | | | - | | | 332 | |
Equity in net income of GELcore investment | | | (21 | ) | | - | | | (21 | ) |
Total other expenses | | | 4,538 | | | - | | | 4,538 | |
Loss from continuing operations | | $ | (21,390 | ) | $ | 1,201 | | $ | (20,189 | ) |
| | | | | | | | | | |
Per share data: | | | | | | | | | | |
Basic and diluted per share data: | | | | | | | | | | |
Loss from continuing operations | | $ | (0.43 | ) | $ | 0.02 | | $ | (0.41 | ) |
| | | | | | | | | | |
Weighted average number of shares outstanding used in basic and diluted per share calculations | | | 49,336 | | | 49,336 | | | 49,336 | |
The accompanying notes are an integral part of these pro forma condensed consolidated financial statements.
EMCORE CORPORATION
Pro Forma Condensed Consolidated Balance Sheet
(in thousands)
(unaudited)
| | | As of June 30, 2006 | |
| | | As reported | | | Pro forma adjustments | | | | Pro forma as adjusted | |
ASSETS | | | | | | | | | | | |
Current assets: | | | | | | | | | | | |
Cash and cash equivalents | | $ | 16,138 | | $ | 13,000 | | (b) | $ | 29,138 | |
Restricted cash | | | 1,303 | | | - | | | | 1,303 | |
Marketable securities | | | 7,900 | | | - | | | | 7,900 | |
Accounts receivable, net | | | 27,388 | | | - | | | | 27,388 | |
Receivables, related parties | | | 482 | | | - | | | | 482 | |
Inventory, net | | | 24,940 | | | (2,988 | ) | (d) | | 21,952 | |
Prepaid expenses and other current assets | | | 3,224 | | | 2,973 | | (c,d) | | 6,197 | |
Total current assets | | | 81,375 | | | 12,985 | | | | 94,360 | |
| | | | | | | | | | | |
Property, plant and equipment, net | | | 56,997 | | | (3,394 | ) | (d) | | 53,603 | |
Goodwill | | | 40,476 | | | - | | | | 40,476 | |
Intangible assets, net | | | 6,624 | | | (178 | ) | (d) | | 6,446 | |
Investments in unconsolidated affiliates | | | 12,388 | | | - | | | | 12,388 | |
Receivables, related parties | | | 169 | | | - | | | | 169 | |
Other assets, net | | | 5,526 | | | (998 | ) | (d) | | 4,528 | |
| | | | | | | | | | | |
Total assets | | $ | 203,555 | | $ | 8,415 | | | $ | 211,970 | |
| | | | | | | | | | | |
LIABILITIES and SHAREHOLDERS’ EQUITY | | | | | | | | | | | |
Current liabilities: | | | | | | | | | | | |
Accounts payable | | $ | 20,692 | | $ | - | | | $ | 20,692 | |
Accrued expenses and other current liabilities | | | 13,540 | | | (606 | ) | (e) | | 12,934 | |
Notes payable, current portion | | | 430 | | | - | | | | 430 | |
Total current liabilities | | | 34,662 | | | (606 | ) | | | 34,056 | |
| | | | | | | | | | | |
Notes payable, long-term | | | 277 | | | - | | | | 277 | |
Convertible subordinated notes, long-term | | | 95,895 | | | - | | | | 95,895 | |
Total liabilities | | | 130,834 | | | (606 | ) | | | 130,228 | |
| | | | | | | | | | | |
Commitments and contingencies | | | | | | | | | | | |
| | | | | | | | | | | |
Shareholders’ equity: | | | | | | | | | | | |
Preferred stock, $0.0001 par, 5,882 shares authorized, no shares outstanding | | | - | | | - | | | | - | |
Common stock, no par value, 100,000 shares authorized, 50,805 shares issued and 50,646 shares outstanding | | | 410,153 | | | - | | | | 410,153 | |
Accumulated deficit | | | (335,349 | ) | | 9,021 | | | | (326,328 | ) |
Treasury stock, at cost, 159 shares | | | (2,083 | ) | | - | | | | (2,083 | ) |
Total shareholders’ equity | | | 72,721 | | | 9,021 | | | | 81,742 | |
| | | | | | | | | | | |
Total liabilities and shareholders’ equity | | $ | 203,555 | | $ | 8,415 | | | $ | 211,970 | |
The accompanying notes are an integral part of these pro forma condensed consolidated financial statements.
EMCORE Corporation
Notes to Unaudited Condensed Consolidated Pro Forma Financial Statements
NOTE 1. Business Divesture.
On August 18, 2006, EMCORE completed the sale of assets of its Electronic Materials & Device division (the "EMD Business"), including inventory, fixed assets, and intellectual property, pursuant to an Asset Purchase Agreement, dated July 19, 2006 (the “Purchase Agreement”), between EMCORE, IQE, plc, a public limited company organized under the laws of the United Kingdom ("IQE"), and IQE RF, LLC, a New Jersey limited liability company and a wholly owned subsidiary of IQE ("Purchaser").
Under the terms of the Purchase Agreement, EMCORE sold the EMD Business to Purchaser for $16.0 million, consisting of a $0.2 million deposit previously delivered to EMCORE, $12.8 million delivered via wire transfer on August 18, 2006, and $3.0 million in the form of a secured promissory note of IQE and Purchaser (the "Note"), guaranteed by IQE's affiliates. The Note is to be repaid in four quarterly installments and bears interest at an annual rate of 7.5%.
NOTE 2. Basis of Presentation.
The preceding unaudited pro forma condensed consolidated financial information presented for the statements of operations for the year ended September 30, 2005 and the nine-month period ended June 30, 2006 is based upon the Company’s historical results of operations, adjusted to reflect the pro forma effect of excluding operations derived from the Company’s EMD Business as of October 1, 2004. The preceding unaudited pro forma condensed consolidated financial information presented for the balance sheet as of June 30, 2006, is based upon the Company’s historical results, adjusted to reflect the pro forma effect of the sale of assets of the EMD Business as if it had occurred on June 30, 2006.
The unaudited pro forma condensed consolidated financial information is presented for illustrative purposes only and is not necessarily indicative of any future results of operations or the results that might have occurred had the disposition actually been completed on the indicated dates.
The historical consolidated financial information presented herein should be read in conjunction with the audited consolidated financial statements and notes thereto appearing in the Company’s Annual Report on Form 10-K for the year ended September 30, 2005, and the unaudited consolidated financial statements and notes thereto included in the Company’s Quarterly Report on Form 10-Q for the nine months ended June 30, 2006.
The Company anticipates a gain on the disposition that has not been reflected in the pro forma statements of operations as the gain is considered to be non-recurring. Pro-forma adjustments included in the pro forma condensed consolidated financial statements are as follows:
a) | The adjustments reflected in the condensed consolidated statements of operations eliminate the results of operations of the EMD Business that was sold to IQE. |
b) | This adjustment in the balance sheet reflects the net cash proceeds from the sale of the EMD Business. |
c) | This adjustment in the balance sheet includes the $3.0 million promissory note due EMCORE as a result of the sale of the EMD Business. |
d) | These adjustments in the balance sheet reflect changes to inventory, prepaid expenses, fixed assets, intellectual property, and other assets being sold or otherwise disposed of as a result of the sale of the EMD Business. Using the carrying value as of the June 30, 2006 consolidated balance sheet, total assets to be disposed of approximate $7.6 million. |
e) | This adjustment in the balance sheet reflects the elimination of various accrued liabilities being assumed by IQE. Using the carrying value as of the June 30, 2006 consolidated balance sheet, total liabilities to be disposed of approximate $0.6 million. |